BRPI0519212A2 - composiÇÕes farmacÊuticas de desintegraÇço oral contendo agentes de manifestaÇço sensorial - Google Patents

composiÇÕes farmacÊuticas de desintegraÇço oral contendo agentes de manifestaÇço sensorial

Info

Publication number
BRPI0519212A2
BRPI0519212A2 BRPI0519212-9A BRPI0519212A BRPI0519212A2 BR PI0519212 A2 BRPI0519212 A2 BR PI0519212A2 BR PI0519212 A BRPI0519212 A BR PI0519212A BR PI0519212 A2 BRPI0519212 A2 BR PI0519212A2
Authority
BR
Brazil
Prior art keywords
agents
pharmaceutical compositions
compositions containing
manifestation
oral disintegrating
Prior art date
Application number
BRPI0519212-9A
Other languages
English (en)
Inventor
Denis George Anthony Nelson
William Michael Nichols
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of BRPI0519212A2 publication Critical patent/BRPI0519212A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Abstract

COMPOSIÇÕES FARMACÊUTICAS DE DESINTEGRAÇçO ORAL CONTENDO AGENTES DE MANIFESTAÇçO SENSORIAL. A presente invenção refere-se a composições que se desintegram na boca e contêm pelo menos um ingrediente farmacêutico sistemicamente ativo em uma quantidade terapeuticamente efetiva e, pelo menos, um agente de manifestação sensorial em uma quantidade efetiva de manifestação sensorial.
BRPI0519212-9A 2004-12-23 2005-12-12 composiÇÕes farmacÊuticas de desintegraÇço oral contendo agentes de manifestaÇço sensorial BRPI0519212A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63852604P 2004-12-23 2004-12-23
PCT/IB2005/003839 WO2006067593A1 (en) 2004-12-23 2005-12-12 Orally disintegrating pharmaceutical compositions with sensory cue agents

Publications (1)

Publication Number Publication Date
BRPI0519212A2 true BRPI0519212A2 (pt) 2009-01-06

Family

ID=36013364

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519212-9A BRPI0519212A2 (pt) 2004-12-23 2005-12-12 composiÇÕes farmacÊuticas de desintegraÇço oral contendo agentes de manifestaÇço sensorial

Country Status (10)

Country Link
US (1) US20060141031A1 (pt)
EP (1) EP1835886A1 (pt)
JP (1) JP2008525420A (pt)
CN (1) CN101102748A (pt)
AU (1) AU2005317739A1 (pt)
BR (1) BRPI0519212A2 (pt)
CA (1) CA2591747A1 (pt)
MX (1) MX2007007885A (pt)
RU (1) RU2007127999A (pt)
WO (1) WO2006067593A1 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10085954B2 (en) 2015-12-18 2018-10-02 The Procter & Gamble Company Quick dissolving diphenhydramine oral dosage form

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1942877A4 (en) * 2005-11-02 2011-09-14 Teikoku Pharma Usa Inc ORGANOLEPTICALLY ACCEPTABLE ORAL DOSAGE FORMS OF IBUPROFEN, MANUFACTURING METHOD AND APPLICATION
US20080220029A1 (en) * 2007-03-05 2008-09-11 Charlene Ng Fast-dissolving/disintegrating film preparation having high proportion of active
EP2002733B1 (en) * 2007-06-08 2016-11-02 The Procter and Gamble Company Natural honey-containing compositions and method of preparation
US8323695B2 (en) 2007-08-13 2012-12-04 Mcneil-Ppc, Inc. Method for stabilizing phenylephrine
US9078824B2 (en) * 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
EP2100595A1 (en) * 2008-03-10 2009-09-16 The Procter and Gamble Company Compressed tablets
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
CN102264345A (zh) * 2008-12-23 2011-11-30 乔舒亚·D·莱文 在药物治疗方案中添加感知调节作用信号的方法
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
JP2013523092A (ja) 2010-03-26 2013-06-17 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 非喫煙用タバコ製品の消費中の感覚刺激の抑制
AU2011234637B2 (en) * 2010-03-29 2013-08-29 Ferring B.V. A fast dissolving pharmaceutical composition
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
KR20120118495A (ko) * 2010-04-21 2012-10-26 테이코쿠 팔마 유에스에이, 인코포레이티드 국부 마취제 에멀전 조성물 및 이의 제조 및 사용 방법
US8906949B2 (en) * 2010-05-21 2014-12-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablets of zolmitriptan and process for preparing the same
US20110300216A1 (en) * 2010-06-03 2011-12-08 First Eric R Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives
CA2848785A1 (en) 2011-09-16 2013-03-21 Ferring B.V. A fast dissolving pharmaceutical composition
US10556011B2 (en) 2011-12-02 2020-02-11 Joshua D. Levine Method and system for adding sensory conditioning cues in a pharmacotherapeutic regimen
RU2673239C2 (ru) * 2013-03-13 2018-11-23 Трис Фарма, Инк. Твердые таблетки и капсулы модифицированного высвобождения бензонатата
US9180104B2 (en) 2013-03-13 2015-11-10 Tris Pharma, Inc. Benzonatate modified release solid tablets and capsules
CN105012254A (zh) * 2015-06-10 2015-11-04 临汾奇林药业有限公司 一种羧甲司坦含片的生产工艺
RU2604576C1 (ru) * 2015-12-01 2016-12-10 Общество С Ограниченной Ответственностью "Валента - Интеллект" Фармацевтическая композиция для лечения инфекционно-воспалительных заболеваний местного применения и способ ее получения и применения
RU2604575C1 (ru) * 2015-12-01 2016-12-10 Общество С Ограниченной Ответственностью "Валента-Интеллект" Фармацевтическая композиция для лечения инфекционно-воспалительных заболеваний местного применения и способ ее получения и применения
US11110035B1 (en) * 2016-02-05 2021-09-07 Gram Tactical Llc Tactical medicine dispensers
WO2018106456A1 (en) * 2016-12-07 2018-06-14 The Board Of Regents Of The University Of Texas System Mouthwash for treating oral cancers
US20200405673A1 (en) * 2019-06-25 2020-12-31 NuBioPharma, LLC Oral solution and powder to liquid compositions of balsalazide
WO2021150178A1 (en) * 2020-01-23 2021-07-29 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Pharmaceutical compositions comprising ibuprofen, pseudoephedrine and ascorbic acid
US20220087997A1 (en) * 2020-09-22 2022-03-24 Fertin Pharma A/S Oral Antagonist Compositions For Nicotine Burning Relief

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515781A (en) * 1967-10-12 1970-06-02 Johnson & Johnson Cold capsule
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
US4853212A (en) * 1987-07-13 1989-08-01 Warner-Lambert Company Reduced base content chewing gum compositions having anesthetic properties
US4822597A (en) * 1987-07-13 1989-04-18 Warner-Lambert Company Anesthetic-containing chewing gum compositions
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
CA2128820A1 (en) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
TW527195B (en) * 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
EP1041965A1 (en) * 1997-12-29 2000-10-11 The Procter & Gamble Company Tablet composition
US20030206942A1 (en) * 1998-09-25 2003-11-06 Neema Kulkarni Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
WO2003009834A1 (en) * 2000-08-17 2003-02-06 Battey Alyce S Oral delivery of pharmaceuticals via encapsulation
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10085954B2 (en) 2015-12-18 2018-10-02 The Procter & Gamble Company Quick dissolving diphenhydramine oral dosage form
US10624845B2 (en) 2015-12-18 2020-04-21 The Procter & Gamble Company Quick dissolving diphenhydramine oral dosage form

Also Published As

Publication number Publication date
WO2006067593A1 (en) 2006-06-29
RU2007127999A (ru) 2009-01-27
EP1835886A1 (en) 2007-09-26
AU2005317739A1 (en) 2006-06-29
MX2007007885A (es) 2007-10-04
US20060141031A1 (en) 2006-06-29
JP2008525420A (ja) 2008-07-17
CA2591747A1 (en) 2006-06-29
CN101102748A (zh) 2008-01-09

Similar Documents

Publication Publication Date Title
BRPI0519212A2 (pt) composiÇÕes farmacÊuticas de desintegraÇço oral contendo agentes de manifestaÇço sensorial
BRPI0414876A (pt) compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
BR0207930A (pt) Composições farmacêuticas lìquidas com sabor mascarado
UY27598A1 (es) Composiciones farmacéuticas de derivados de taxano oralmente activos que tienen biodisponibilidad mejorada
GT200600194A (es) Composiciones farmaceuticas conteniendo imatinib y un componente de liberacion prolongada
CO5190672A1 (es) Composicion para la dosificacion oral, de disolucion instantanea
HN1999000210A (es) Composiciones de celecoxib
AU2003304237A8 (en) Gel-stabilized nanoparticulate active agent compositions
BR0005938A (pt) Composição de dosagem oral com libaraçãoprolongada
SG157406A1 (en) Oral medicament for the modified release of at least one active principle, in multi-microcapsule form
BRPI0412489A (pt) composição de confeito mastigável liberando para as superfìcies dentárias uma dose unitária de uma enzima
BR0209327A (pt) Composição para tratamento de constipação induzida por drogas
BR0316236A (pt) Dispositivo polimérico de dissolução controlada para cavidade oral
WO2008042480A3 (en) Epoxide inhibitors of cysteine proteases
PT1423168E (pt) Composicao farmaceutica que compreende gabapentina ou um seu analogo e uma x-aminoamida e a sua utilizacao como analgesico
BR9914419A (pt) Terapia para melhoria da percepção
PE20150773A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
ECSP003807A (es) Composiciones valdecoxib
HUP0401200A2 (hu) Terbinafint tartalmazó gyógyszerészeti összetételek és eljárás előállításukra
BR0012696A (pt) Composição oftálmica
BRPI0417416A (pt) composição de confeitaria de branqueamento de dentes oral sólida
MA27102A1 (fr) Composition pharmaceutique orodispersible d'ivabradine
MA27099A1 (fr) Composition pharmaceutique orodispersible de perindopril
BR0313177A (pt) Administração oral de calcitonina
BR0014440A (pt) Formulações de liberação controlada oral

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.